By Zacks Equity Research The international business of NuVasive, Inc. NUVA, a medical device player in the global spine market, recently got a boost with the Shonin approval for its Reline posterior fixation technology in Japan. Following this regulatory clearance, the Reline launch will begin later this year in Japan and continue into 2017. The approval […]